Tag Archives: Roivant

Mountains and Molehills

First, the Mountain: Denali Therapeutics made their May debut with the announcement that they raised $217 million in a Series A, a very dynamic bit of BioTheatre. Indeed, it is as compelling a headline as we have seen thus far … Continue reading

Posted in Big Pharma, BioFollies, Biotech | Tagged , , , | 1 Comment